Tech Company Financing Transactions

Appili Therapeutics Funding Round

Appili Therapeutics closed a $3.1 million Seed financing round on 10/24/2017. Backers included Innovacorp and private investors.

Transaction Overview

Announced On
10/24/2017
Transaction Type
Venture Equity
Amount
$3,062,000
Round
Seed
Investors

Innovacorp (Lidija Maru�ic)

Proceeds Purpose
Proceeds from the financing will be used to fund operations and the continued growth of the company. Specifically, the additional funding will enable Appili to advance its pipeline of anti-infectives and move its lead antibiotic, a taste-masked treatment for anaerobic infections, into the clinic.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1344 Summer St. 21
Halifax NS, B3H 0A8
Canada
Email Address
Overview
Appili Therapeutics is developing novel approaches to lead the fight against infectious disease. Despite numerous achievements in the development of anti-infectives, infectious disease remains the leading cause of death worldwide.
Profile
Appili Therapeutics LinkedIn Company Profile
Social Media
Appili Therapeutics Company Twitter Account
Company News
Appili Therapeutics News
Facebook
Appili Therapeutics on Facebook
YouTube
Appili Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Kevin Sullivan
  Kevin Sullivan LinkedIn Profile  Kevin Sullivan Twitter Account  Kevin Sullivan News  Kevin Sullivan on Facebook
Chief Financial Officer
Kimberly Stephens
  Kimberly Stephens LinkedIn Profile  Kimberly Stephens Twitter Account  Kimberly Stephens News  Kimberly Stephens on Facebook
VP - Bus. Development
Armand Balboni
  Armand Balboni LinkedIn Profile  Armand Balboni Twitter Account  Armand Balboni News  Armand Balboni on Facebook
VP - Manufacturing
Myriam Triest
  Myriam Triest LinkedIn Profile  Myriam Triest Twitter Account  Myriam Triest News  Myriam Triest on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/24/2017: ActionIQ venture capital transaction
Next: 10/24/2017: Vouchr venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document tech company VC transactions. VC investment data records on this site are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary